Nalaganje...
Intra‐arterial renal infusion of autologous mesenchymal stem cells for treatment of chronic kidney disease in cats: Phase I clinical trial
BACKGROUND: There are no known treatments that halt or reverse chronic kidney disease (CKD) in cats. In rodent models, stem cell treatment has been associated with improvement in renal function parameters, especially when stem cells were delivered intra‐arterially to the kidney. To date, only IV and...
Shranjeno v:
| izdano v: | J Vet Intern Med |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Inc.
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6524114/ https://ncbi.nlm.nih.gov/pubmed/30924554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.15486 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|